Search Results for 'Ns5a'

Ns5a published presentations and documents on DocSlides.

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

tawny-fly
28 Slides

Mark Sulkowski, MD. Associate Professor of Medici...

Newest Drugs for Hepatitis C

Newest Drugs for Hepatitis C

tawny-fly
16 Slides

Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...

No randomisation

No randomisation

pamella-moone
6 Slides

Open-label. 18-70 years. HCV genotype 1. Naïve o...

SOF/VEL + RBV

SOF/VEL + RBV

celsa-spraggs
5 Slides

N = 69. >. 18 years. Failure to SOF/VEL . or ...

Forns

Forns

ellena-manuel
6 Slides

X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...

SOF/VEL/VOX

SOF/VEL/VOX

pamella-moone
7 Slides

400/100/100 mg QD. N = 263. N = 152. W12. Placebo...

Not randomised Open-label

Not randomised Open-label

phoebe-click
0 Slides

18-70 years. Naïve . or failure to. PEG-IFN RB...

HIV Pipeline Doravirine 2

HIV Pipeline Doravirine 2

giovanna-bartolotta
0 Slides

(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...

HIV Pipeline Cabotegravir-LA

HIV Pipeline Cabotegravir-LA

liane-varnes
0 Slides

(GSK-744; CAB). For . PrEP. INI. ViiV. Topical mi...

NS5A and polymerase inhibitors

NS5A and polymerase inhibitors

LoveBug
16 Slides

Mark Sulkowski, MD. Professor of Medicine. Johns H...

The Paradox of Highly Effective

The Paradox of Highly Effective

Kingslayer
20 Slides

Sofosbuvir. . Combo Therapy . Despite . Slow . He...

The Role of Diagnostics in the Management of HCV and HIV

The Role of Diagnostics in the Management of HCV and HIV

zoe
44 Slides

Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...

Virological characterization of patients with CHC and failure to a

Virological characterization of patients with CHC and failure to a

isabella2
18 Slides

glecaprevir. /. pibrentasvir. or . voxilaprevir. ...

Copyright © 2024 DocSlides. All Rights Reserved